Clinical need for continuous glucose monitoring in the hospital.
Automation and standardization of the glucose measurement process have the potential to greatly improve glycemic control, clinical outcome, and safety while reducing cost. The resources required to monitor glycemia in hospitalized patients have thus far limited the implementation of intensive glucose management to patients in critical care units. Numerous available and up-and-coming technologies are targeted for the hospital patient population. Advantages and limitations of these devices are discussed herewith in.
The Artificial Pancreas Center, Department of Anesthesiology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. jeffrey.joseph@jefferson.edu
Jeffrey I
JI
Joseph
Brian
B
Hipszer
Boris
B
Mraovic
Inna
I
Chervoneva
Mark
M
Joseph
Zvi
Z
Grunwald
D001331:Automation; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation / Q000592:standards; D019719:Diagnostic Equipment; D004867:Equipment Design; D005947:Glucose / Q000008:administration & dosage; D006760:Hospitalization; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D007003:Hypoglycemia / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007297:Inpatients; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems; D011237:Predictive Value of Tests; D013997:Time Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D005947:Glucose